201 related articles for article (PubMed ID: 24302429)
1. Specificity of a UDP-GalNAc pyranose-furanose mutase: a potential therapeutic target for Campylobacter jejuni infections.
Poulin MB; Shi Y; Protsko C; Dalrymple SA; Sanders DA; Pinto BM; Lowary TL
Chembiochem; 2014 Jan; 15(1):47-56. PubMed ID: 24302429
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a bifunctional pyranose-furanose mutase from Campylobacter jejuni 11168.
Poulin MB; Nothaft H; Hug I; Feldman MF; Szymanski CM; Lowary TL
J Biol Chem; 2010 Jan; 285(1):493-501. PubMed ID: 19887444
[TBL] [Abstract][Full Text] [Related]
3. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues.
Chad JM; Sarathy KP; Gruber TD; Addala E; Kiessling LL; Sanders DA
Biochemistry; 2007 Jun; 46(23):6723-32. PubMed ID: 17511471
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of the Campylobacter jejuni Cj1294, a novel UDP-4-keto-6-deoxy-GlcNAc aminotransferase that generates UDP-4-amino-4,6-dideoxy-GalNAc.
Obhi RK; Creuzenet C
J Biol Chem; 2005 May; 280(21):20902-8. PubMed ID: 15790564
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic synthesis of UDP-(3-deoxy-3-fluoro)-D-galactose and UDP-(2-deoxy-2-fluoro)-D-galactose and substrate activity with UDP-galactopyranose mutase.
Barlow JN; Blanchard JS
Carbohydr Res; 2000 Oct; 328(4):473-80. PubMed ID: 11093703
[TBL] [Abstract][Full Text] [Related]
6. Exploring the mechanism of binding of UDP-galactopyranose to UDP-galactopyranose mutase by STD-NMR spectroscopy and molecular modeling.
Yuan Y; Wen X; Sanders DA; Pinto BM
Biochemistry; 2005 Nov; 44(43):14080-9. PubMed ID: 16245924
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP.
Partha SK; van Straaten KE; Sanders DA
J Mol Biol; 2009 Dec; 394(5):864-77. PubMed ID: 19836401
[TBL] [Abstract][Full Text] [Related]
8. Galactofuranose biosynthesis in Escherichia coli K-12: identification and cloning of UDP-galactopyranose mutase.
Nassau PM; Martin SL; Brown RE; Weston A; Monsey D; McNeil MR; Duncan K
J Bacteriol; 1996 Feb; 178(4):1047-52. PubMed ID: 8576037
[TBL] [Abstract][Full Text] [Related]
9. UDP-galactopyranose mutase has a novel structure and mechanism.
Sanders DA; Staines AG; McMahon SA; McNeil MR; Whitfield C; Naismith JH
Nat Struct Biol; 2001 Oct; 8(10):858-63. PubMed ID: 11573090
[TBL] [Abstract][Full Text] [Related]
10. A unique catalytic mechanism for UDP-galactopyranose mutase.
Soltero-Higgin M; Carlson EE; Gruber TD; Kiessling LL
Nat Struct Mol Biol; 2004 Jun; 11(6):539-43. PubMed ID: 15133501
[TBL] [Abstract][Full Text] [Related]
11. Steric Control of the Rate-Limiting Step of UDP-Galactopyranose Mutase.
Pierdominici-Sottile G; Cossio-Pérez R; Da Fonseca I; Kizjakina K; Tanner JJ; Sobrado P
Biochemistry; 2018 Jul; 57(26):3713-3721. PubMed ID: 29757624
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and inhibition properties of conformational probes for the mutase-catalyzed UDP-galactopyranose/furanose interconversion.
Caravano A; Mengin-Lecreulx D; Brondello JM; Vincent SP; Sinaÿ P
Chemistry; 2003 Dec; 9(23):5888-98. PubMed ID: 14673861
[TBL] [Abstract][Full Text] [Related]
13. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
[TBL] [Abstract][Full Text] [Related]
14. Contributions of unique active site residues of eukaryotic UDP-galactopyranose mutases to substrate recognition and active site dynamics.
Da Fonseca I; Qureshi IA; Mehra-Chaudhary R; Kizjakina K; Tanner JJ; Sobrado P
Biochemistry; 2014 Dec; 53(49):7794-804. PubMed ID: 25412209
[TBL] [Abstract][Full Text] [Related]
15. Tetrafluorination of sugars as strategy for enhancing protein-carbohydrate affinity: application to UDP-Galp mutase inhibition.
N'Go I; Golten S; Ardá A; Cañada J; Jiménez-Barbero J; Linclau B; Vincent SP
Chemistry; 2014 Jan; 20(1):106-12. PubMed ID: 24311368
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues.
van Straaten KE; Kuttiyatveetil JR; Sevrain CM; Villaume SA; Jiménez-Barbero J; Linclau B; Vincent SP; Sanders DA
J Am Chem Soc; 2015 Jan; 137(3):1230-44. PubMed ID: 25562380
[TBL] [Abstract][Full Text] [Related]
17. A single bifunctional UDP-GlcNAc/Glc 4-epimerase supports the synthesis of three cell surface glycoconjugates in Campylobacter jejuni.
Bernatchez S; Szymanski CM; Ishiyama N; Li J; Jarrell HC; Lau PC; Berghuis AM; Young NM; Wakarchuk WW
J Biol Chem; 2005 Feb; 280(6):4792-802. PubMed ID: 15509570
[TBL] [Abstract][Full Text] [Related]
18. Investigation of binding of UDP-Galf and UDP-[3-F]Galf to UDP-galactopyranose mutase by STD-NMR spectroscopy, molecular dynamics, and CORCEMA-ST calculations.
Yuan Y; Bleile DW; Wen X; Sanders DA; Itoh K; Liu HW; Pinto BM
J Am Chem Soc; 2008 Mar; 130(10):3157-68. PubMed ID: 18278916
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the UDP-N-acetylgalactosamine binding domain of bovine polypeptide alphaN-acetylgalactosaminyltransferase T1.
Duclos S; Da Silva P; Vovelle F; Piller F; Piller V
Protein Eng Des Sel; 2004 Aug; 17(8):635-46. PubMed ID: 15377782
[TBL] [Abstract][Full Text] [Related]
20. N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL.
van Sorge NM; Bleumink NM; van Vliet SJ; Saeland E; van der Pol WL; van Kooyk Y; van Putten JP
Cell Microbiol; 2009 Dec; 11(12):1768-81. PubMed ID: 19681908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
